substance p has been researched along with Prader-Willi Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Ding, F; Lin, D; Liu, K; Liu, R; Liu, Y; Ran, H; Sun, Y; Wang, J; Wang, Q; Wang, Y | 1 |
| Greer, JJ; Pagliardini, S; Rent, J; Wevrick, R | 1 |
2 other study(ies) available for substance p and Prader-Willi Syndrome
| Article | Year |
|---|---|
Abnormal response to the anorexic effect of GHS-R inhibitors and exenatide in male Snord116 deletion mouse model for Prader-Willi syndrome.
Topics: Analysis of Variance; Animals; Anorexia; Disease Models, Animal; Eating; Exenatide; Fasting; Ghrelin; Humans; Hyperphagia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Peptides; Piperidines; Prader-Willi Syndrome; Quinazolinones; Receptors, Ghrelin; RNA, Small Nucleolar; Substance P; Venoms | 2014 |
Neurodevelopmental abnormalities in the brainstem of prenatal mice lacking the Prader-Willi syndrome gene Necdin.
Topics: Animals; Apnea; Brain Stem; Mice; Mice, Knockout; Neoplasm Proteins; Nerve Tissue Proteins; Nuclear Proteins; Prader-Willi Syndrome; Substance P; Synapses; Thyrotropin-Releasing Hormone | 2008 |